Atea Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $13k | 2.3k | 5.38 |
| 2023-06-30 | $302k | 90k | 3.35 |
| 2023-03-31 | $302k | 90k | 3.35 |
| 2022-12-31 | $433k | 90k | 4.81 |
| 2022-09-30 | $498k | 87k | 5.69 |
| 2022-06-30 | $721k | 102k | 7.10 |
| 2022-03-31 | $117k | 16k | 7.22 |
| 2021-12-31 | $144k | 16k | 8.94 |
| 2021-09-30 | $443k | 13k | 35.06 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas